Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3855 Health Sciences Dr
La Jolla, CA 92037Phone+1 858-657-7876- Is this information wrong?
Summary
- Yu-Wei Chen, MD, MS, is a board-certified medical oncologist who subspecializes in genitourinary (GU) oncology, treating prostate, kidney, bladder and testicular cancers. As a GU medical oncologist, Dr. Chen is trained in using systemic therapies (e.g., immunotherapy, targeted therapy, hormonal therapy, and chemotherapy) to treat patients with GU malignancies.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
Cleveland Clinic FoundationResidency, Internal Medicine, 2016 - 2019
Harvard T. H. Chan School of Public HealthMS, Epidemiology, 2013 - 2015- National Cheng Kung University College of MedicineClass of 2012, MD
Certifications & Licensure
CA State Medical License 2019 - 2025
MA State Medical License 2019 - 2024
TN State Medical License 2020 - 2023
OH State Medical License 2016 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- ASCO Young Investigator Award Conquer Cancer Foundation, 2022
- ASCO Merit Award Conquer Cancer Foundation, 2022
- Methods in Clinical Cancer Research Workshop Participant ASCO/AACR, 2021
- Join now to see all
Publications & Presentations
PubMed
- The incidence, pathogenesis, and management of non-clear cell renal cell carcinoma.Priyanka Naik, Harshitha Dudipala, Yu-Wei Chen, Brent Rose, Aditya Bagrodia, Rana R McKay> ;Therapeutic Advances in Urology. 2024 Feb 29
- Large-Scale Cancer Genomic Analysis Reveals Significant Disparities Between Microsatellite Instability and Tumor Mutational Burden.Choi, J., Park, K., Kim, Y., Sa, J., Sung, H., Chen, Z., Li, C., Wen, W., Zhang, Q., Shu, X., Zheng, W., Kim, J., Guo, X., Chen, Y.> ;Cancer Epidemiology, Biomarkers & Prevention. 2024 Feb 23
- Treatment Landscape of Renal Cell Carcinoma.Yu-Wei Chen, Luke Wang, Justine Panian, Sohail Dhanji, Ithaar Derweesh, Brent Rose, Aditya Bagrodia, Rana R McKay> ;Current Treatment Options in Oncology. 2023 Dec 1
- Join now to see all
Authored Content
- Treatment Options After First-Line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell CarcinomaDecember 2023
- Adjuvant Pembrolizumab After Nephrectomy in Renal Cell Carcinoma: Embracing the Promises and Acknowledging the UncertaintiesFebruary 2022
Press Mentions
Advanced Kidney Cancer Research: Insights from IKCS 2021December 4th, 2021
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin), Taiwanese
Hospital Affiliations
UC San Diego Medical Center - HillcrestSan Diego, California
External Links
- UC San Diego Health Profilehttps://providers.ucsd.edu/details/1245694801/medical-oncology-urology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
